From animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection

dc.catalogadoryvc
dc.contributor.authorSoto, J. A.
dc.contributor.authorGálvez, N. M. S
dc.contributor.authorRivera, D. B
dc.contributor.authorDíaz, F. E.
dc.contributor.authorRiedel, C. A.
dc.contributor.authorBueno Ramirez, Susan Marcela
dc.contributor.authorKalergis, Alexis M.
dc.date.accessioned2024-03-18T20:19:28Z
dc.date.available2024-03-18T20:19:28Z
dc.date.issued2022
dc.fuente.origenORCID
dc.identifier.doi10.1080/17460441.2022.2123468
dc.identifier.urihttps://doi.org/10.1080/17460441.2022.2123468
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/84634
dc.information.autorucFacultad de Ciencias Biológicas; Bueno Ramirez, Susan Marcela; 0000-0002-7551-8088; 113541
dc.language.isoen
dc.nota.accesoContenido completo
dc.rightsacceso restringido
dc.subjectHuman respiratory syncytial virus
dc.subjectanimal models
dc.subjectvaccines
dc.subjecttherapies
dc.titleFrom animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection
dc.typeartículo
sipa.codpersvinculados113541
sipa.trazabilidadORCID-ene15
Files